Open AccessPretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
Author(s) -
Sophie Park,
Jaideep Shenoi,
Shani M. Frayo,
Donald K. Hamlin,
Yukang Lin,
D. Scott Wilbur,
Patrick S. Stayton,
Nural N. Orgun,
Mark D. Hylarides,
Franz Buchegger,
Aimee L. Kenoyer,
Amanda Axtman,
Ajay K. Gopal,
Damian J. Green,
John M. Pagel,
Oliver W. Press
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/w76e-ms81
Subject(s) - radioimmunotherapy , streptavidin , genetically engineered , fusion protein , lymphoma , fusion , antibody , cancer research , medicine , chemistry , monoclonal antibody , immunology , recombinant dna , biochemistry , biotin , linguistics , philosophy , gene